Researchers have determined that a human gene present in 75% of the population is a key reason why a class of drugs for Alzheimer’s disease seemed promising in animal studies only to fail in human studies.
First clinical proof that genotypes determine if Alzheimer’s drugs will work
Researchers have determined that a human gene present in 75% of the population is a key reason why a class of drugs for Alzheimer’s disease seemed promising in animal studies only to fail in human studies.